Samson Yun-Sang Chan - Search Results

Year	Number of Results
2014	4
2015	4
2017	1
2022	1
2024	1

1

Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial.

Teoh JY, Liu AQ, Yuen VW, Lai FP, Yuen SK, Chan SY, Wong JH, Li JK, Tam MH, Chiu PK, Yee SC, Ng CF. Teoh JY, et al. Among authors: chan sy. Cancers (Basel). 2022 Sep 15;14(18):4476. doi: 10.3390/cancers14184476. Cancers (Basel). 2022. PMID: 36139636 Free PMC article.

2

A prospective cohort of men with localized prostate cancer on active surveillance protocol in Hong Kong, China: what did we learn?

Wu X, Ko IC, Hong CY, Yee SC, Teoh JY, Chan SY, Tam HM, Chan CK, Ng CF, Chiu PK. Wu X, et al. Among authors: chan sy. Asian J Androl. 2024 Jan 26. doi: 10.4103/aja202373. Online ahead of print. Asian J Androl. 2024. PMID: 38284779 Free article.

3

Risk of new-onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF. Teoh JY, et al. Among authors: chan sy. J Diabetes. 2015 Sep;7(5):672-80. doi: 10.1111/1753-0407.12226. Epub 2014 Dec 22. J Diabetes. 2015. PMID: 25266491

4

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level.

Teoh JY, Tsu JH, Yuen SK, Chan SY, Chiu PK, Wong KW, Ho KL, Hou SS, Ng CF, Yiu MK. Teoh JY, et al. Among authors: chan sy. Asia Pac J Clin Oncol. 2017 Apr;13(2):e65-e71. doi: 10.1111/ajco.12313. Epub 2014 Dec 3. Asia Pac J Clin Oncol. 2017. PMID: 25471685

5

Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF. Teoh JY, et al. Among authors: chan sy. Jpn J Clin Oncol. 2015 May;45(5):483-7. doi: 10.1093/jjco/hyv025. Epub 2015 Feb 26. Jpn J Clin Oncol. 2015. PMID: 25724216

6

Prognostic significance of time to prostate-specific antigen (PSA) nadir and its relationship to survival beyond time to PSA nadir for prostate cancer patients with bone metastases after primary androgen deprivation therapy.

Teoh JY, Tsu JH, Yuen SK, Chan SY, Chiu PK, Lee WM, Wong KW, Ho KL, Hou SS, Ng CF, Yiu MK. Teoh JY, et al. Among authors: chan sy. Ann Surg Oncol. 2015 Apr;22(4):1385-91. doi: 10.1245/s10434-014-4105-8. Epub 2014 Sep 19. Ann Surg Oncol. 2015. PMID: 25234025

7

Role of PSA density in diagnosis of prostate cancer in obese men.

Chiu PK, Teoh JY, Chan SY, Chu PS, Man CW, Hou SM, Ng CF. Chiu PK, et al. Among authors: chan sy. Int Urol Nephrol. 2014 Dec;46(12):2251-4. doi: 10.1007/s11255-014-0826-7. Epub 2014 Sep 9. Int Urol Nephrol. 2014. PMID: 25201460

8

Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF. Teoh JY, et al. Among authors: chan sy. Aging Male. 2015;18(3):180-5. doi: 10.3109/13685538.2015.1046043. Epub 2015 May 25. Aging Male. 2015. PMID: 26004988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year